Allison C. Hoffman Sells 3,496 Shares of Phreesia, Inc. (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHR) General Counsel Allison C. Hoffman sold 3,496 shares of the firm’s stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $29.72, for a total value of $103,901.12. Following the transaction, the general counsel now directly owns 142,630 shares of the company’s stock, valued at $4,238,963.60. This represents a 2.39 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

Phreesia Stock Performance

NYSE PHR traded down $1.20 during trading hours on Thursday, hitting $28.49. The company’s stock had a trading volume of 346,852 shares, compared to its average volume of 382,462. Phreesia, Inc. has a 12 month low of $17.07 and a 12 month high of $30.53. The company’s 50 day simple moving average is $27.14 and its two-hundred day simple moving average is $23.77. The company has a market cap of $1.66 billion, a P/E ratio of -19.38 and a beta of 0.96. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.74 and a quick ratio of 1.74.

Phreesia (NYSE:PHR) last released its quarterly earnings results on Monday, December 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.04. The business had revenue of $106.80 million during the quarter, compared to the consensus estimate of $106.33 million. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The business’s quarterly revenue was up 16.6% compared to the same quarter last year. During the same period in the previous year, the company posted ($0.58) EPS. As a group, sell-side analysts expect that Phreesia, Inc. will post -1.1 EPS for the current fiscal year.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the company. JMP Securities reaffirmed a “market outperform” rating and issued a $30.00 price target on shares of Phreesia in a research report on Tuesday, December 10th. Truist Financial lifted their price target on Phreesia from $31.00 to $34.00 and gave the stock a “buy” rating in a research report on Wednesday, December 11th. Royal Bank of Canada raised Phreesia from a “sector perform” rating to an “outperform” rating and lifted their price target for the stock from $24.00 to $32.00 in a research report on Wednesday, January 8th. Citigroup lifted their price target on Phreesia from $31.00 to $35.00 and gave the stock a “buy” rating in a research report on Friday, January 10th. Finally, KeyCorp lifted their price target on Phreesia from $28.00 to $30.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 8th. Thirteen investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus price target of $31.15.

Institutional Investors Weigh In On Phreesia

Large investors have recently made changes to their positions in the company. Johnson Financial Group Inc. grew its stake in shares of Phreesia by 381.3% during the 4th quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company’s stock valued at $28,000 after purchasing an additional 896 shares during the period. R Squared Ltd bought a new stake in shares of Phreesia during the 4th quarter valued at about $30,000. BankPlus Trust Department bought a new position in shares of Phreesia during the 4th quarter valued at approximately $34,000. International Assets Investment Management LLC grew its stake in shares of Phreesia by 2,179.7% during the 3rd quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock valued at $33,000 after acquiring an additional 1,395 shares during the period. Finally, Quarry LP grew its stake in shares of Phreesia by 210.9% during the 4th quarter. Quarry LP now owns 2,835 shares of the company’s stock valued at $71,000 after acquiring an additional 1,923 shares during the period. 92.10% of the stock is currently owned by institutional investors.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.